Article

mRNA: vaccine or gene therapy? The safety regulatory issues

2023-06-26

Abstract excerpt

COVID-19 vaccines were developed and approved rapidly in response to the urgency created by the pandemic. No specific regulations existed at the time they were marketed. The regulatory agencies therefore adapted them as a matter of urgency. Now that the pandemic emergency has passed, it's time to consider the safety issues associated with this rapid approval. The mode of action of COVID-19 mRNA vaccines should cla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 28d77e6d-4b0d-5c0f-a937-2ae8b132b9ab
DOI: 10.32388/ww4uen.3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

mRNA: vaccine or gene therapy? The safety regulatory issuesDOI 10.32388/ww4uen.3Read

mRNA-based therapeutics: looking beyond COVID-19 vaccinesSemantic proximity Read

mRNA-based modalities for infectious disease managementSemantic proximity Read

mRNA therapeutics: beyond vaccine applicationsSemantic proximity Read

mRNA vaccines in the prevention and treatment of diseasesSemantic proximity Read

The dawn of mRNA vaccines: The COVID-19 caseSemantic proximity Read

Safety of mRNA COVID-19 vaccines during pregnancySemantic proximity Read

mRNA vaccines for infectious diseases: principles, delivery and clinical translationSemantic proximity Read

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!Semantic proximity Read

mRNA Vaccine Technology Beyond COVID-19Semantic proximity Read

Mucosal mRNA Vaccines. Merits and PerspectivesSemantic proximity Read

mRNA cancer vaccines: Advances, trends and challengesSemantic proximity Read

Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity Read